A fusion protein of hepatocyte growth factor for immobilization to collagen
A fusion protein of hepatocyte growth factor for immobilization to collagen
复制标题
DOI:
10.1016/j.biomaterials.2006.12.022
复制
发表时间:
2007-04-01
期刊:
影响因子:
14
通讯作者:
Ito, Yoshihiro
中科院分区:
文献类型:
--
作者:
Kitajima, Takashi;Terai, Hiroshi;Ito, Yoshihiro
We describe here a fusion protein consisting of hepatocyte growth factor (HGF; an angiogenic factor) and a collagen-binding domain (CBD) polypeptide of fibronectin (FN). This fusion protein (CBD-HGF), produced by a baculovirus expression system, exhibited much stronger collagen binding activity than native HGF in the range of 0.4-6.4 mu g/ml. Its binding at the lowest concentration exceeded that of HGF at the highest concentration. In addition, the collagen-bound CBD-HGF promoted growth of endothelial cells (ECs) to a greater degree at least 4 days longer than HGF added to the culture medium; about 5-fold greater increase in cell number after 10 days. These findings suggest that the fused CBD moiety not only helped immobilize HGF on collagen but also helped stabilize the fusion molecule, resulting in prolonged activity. The angiogenic activity of CBD-HGF in animal tissues was examined by subcutaneously implanting collagen sponges containing bound CBD-HGF. Blood vessel formation in the sponges after 7 days was 4-6-fold extensive as compared to the control sponges without sample. Implanted sponges with native HGF did not show significant difference from control. These results indicate that CBD-HGF is suitable for in vitro culture of ECs, and that this fusion protein can be used to confer HGF activity on biornaterials for use in tissue engineering. (c) 2007 Elsevier Ltd. All rights reserved.